Pimadipine Tablets 30/2.5 mg (Pimasartan Potassium, Esamlodipine)
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
MFDS item code 202204661 · Approved 2022.12.27
Treatment of essential hypertension not controlled with fimasartan monotherapy
This medicine is used as an adjunct for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of Pimasartan potassium, helping to control blood pressure more effectively. In other words, it is used to lower blood pressure in cases where existing treatment cannot control hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Pediatric patients The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug's active ingredients or similar medications, pregnant or nursing women, kidney dialysis patients, and those with severe liver dysfunction should not take this medication. Patients with depleted blood volume or decreased salt, those with impaired kidney function, and patients with certain heart valve diseases should use this drug cautiously and monitor their condition carefully while taking it. Side effects such as dizziness, headache, facial swelling, urinary problems, insomnia, and flushing may occur; if any unusual symptoms arise, consult a physician. Due to its effect of lowering blood pressure, symptoms of hypotension may appear, so extra caution is needed, especially when starting therapy or increasing the dosage. Patients with heart failure or poor liver function may be more affected by this drug, so consultation with the attending physician is recommended. Be cautious when driving or operating machinery, as dizziness or drowsiness may occur. This drug may interact with other blood pressure medications, certain diuretics, and potassium supplements, so it is essential to inform your physician of any other medications being taken. Women who are pregnant or planning to become pregnant should not take this medication, and it is also recommended that nursing mothers avoid its use. Safety and efficacy have not been established for use in children or adolescents under 18 years old, so it is best not to use it. In case of overdose, serious hypotension or heart-related issues may occur, and immediate medical attention is required. Store this medication out of reach of children and do not transfer it to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that protects it from light, preferably at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy for a long time.
White, round-shaped film-coated tablets
Bottle packaging - 30 tablets/bottle, bottle packaging - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Allyco Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Hana Pharm Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Korea Hutech Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.